Home > Health > Pharmacy > Drugs and Medications > L > Lapatinib
Lapatinib is classified as a signal transduction inhibitor - tyrosine kinase inhibitor, inhibitor of EGFR and HER2. Lapatinib is marketed as Tykerb and is used in the treatment of metastatic breast cancer that is HER-2 positive. The drug may also be used in combination with other chemotherapy drugs or for the treatment of other cancers.
http://www.rxlist.com/cgi/generic/tykerb.htm
Provides medication description and drug information including side effects, interactions, and patient labeling.
Home > Health > Pharmacy > Drugs and Medications > L > Lapatinib
Thanks to DMOZ, which built a great web directory for nearly two decades and freely shared it with the web. About us